PhD Students

TU Wien

Projektass.in Ing.in Raluca Dobre MSc

Projektass.in Ing.in Raluca Dobre MSc

Projektassistentin, Research Group for Bioorganic Synthetic Chemistry

Send email to Raluca Dobre

Show room BI02A09 on the map , opens an external URL in a new window

Getreidemarkt 9, 1060 Wien, Austria

Projektass.in Nika Podlesnik MSc

Projektass.in Nika Podlesnik MSc

Projektassistentin, Research Group for Bioorganic Synthetic Chemistry

Send email to Nika Podlesnik

Show room BI02G10 on the map , opens an external URL in a new window

Getreidemarkt 9, 1060 Wien, Austria

Projektass. Dipl.-Ing. Alexander Trischack BSc

Projektass. Dipl.-Ing. Alexander Trischack BSc

Projektassistent, Research Group for Computational Fluid Dynamics (CFD)

+43 1 58801 166272

Send email to Alexander Trischack

Show room BI03A19 on the map , opens an external URL in a new window

Getreidemarkt 9, 1060 Wien, Austria

Vienna University

Miriam CIALLELLA

Profile Picture Miriam CIALLELLA

My doctoral project focuses on developing a sustainable method for recycling polymeric

materials through an innovative electro-photocatalytic approach, in collaboration with

BASF . The increasing demand for a circular plastic economy highlights the need for efficient

strategies to recover high-value monomers from PU waste. Conventional recycling methods

face limitations due to the high stability and crosslinked nature of polyurethane networks. To

address this, the proposed method aims to combine photochemical and electrochemical

processes to achieve the energy for selective bond activation (C-O and C-N) and controlled

depolymerization towards an efficient recovery of virgin-grade monomers while minimizing

energy consumption and environmental impact.

Bjarne Schulz

In collaboration with Boehringer Ingelheim, we aim to address the problem of pharmaceutical residues in wastewater. Many drugs are not  fully metabolized in the human body and are subsequently excreted, where  they can accumulate in the environment and pose risks to ecosystems and  human health. Our approach is to design photocleavable bioisosteres that can be incorporated into a wide range of drugs without diminishing their therapeutic efficacy. Once exposed to visible light — for example, sunlight — these bioisosteres undergo cleavage, breaking down the parent
compound into fragments that are biologically inactive.